Eimskip: Transaction In Relation To A Share Buy-Back Program

2025-11-17 03:31:52

(MENAFN- GlobeNewsWire - Nasdaq) Eimskip: Transaction in relation to a share buy-back program

In week 46 2025 Eimskip purchased 175,000 of its own shares, at a purchase price of ISK 49,945,000 as further stipulated below:

Date	Time	No. of shares	Share price	Purchase price
10.11.2025	11:38	15,000	298	4,470,000
10.11.2025	11:43	20,000	298	5,960,000
11.11.2025	10:20	35,000	296	10,360,000
12.11.2025	09:41	35,000	288	10,080,000
13.11.2025	09:48	35,000	282	9,870,000
14.11.2025	10:04	35,000	263	9,205,000

The trade is in accordance with Eimskip's buy-back program as published on Nasdaq Iceland on 29 September 2025. The number of shares to be acquired under the buy-back program will be up to 2,250,000, at a total purchase price which may not exceed ISK 750,000,000. The buy-back program is in effect for 18 months post the Annual General Meeting held 27 March 2025, unless the conditions for maximum purchase are met before that time.

Under current buy-back program Eimskip has purchased a total of 1,074,680 shares in the company, with a total purchase price is ISK 358,498,000.

Eimskip held 2,625,000 shares prior to the notified transactions, and holds 2,800,000 after them, or the equivalent of 1.69% of issued shares in the company.

The execution of the buy-back program must comply with the Act on Public Limited Companies, No. 2/1995. In addition, the buy-back program will be implemented in accordance with Regulation (EU) No. 596/2014 on market abuse, as well as Commission Delegated Regulation (EU) 2016/1052 with regard to regulatory technical standards for the conditions applicable to buy-back programmes, and the Icelandic Act on Measures Against Market Abuse No. 60/2021.

For further information please contact
Guðbjörg Birna Björnsdóttir, Head of Treasury and Investor Relations, tel: +354 844 4752, email:...

MENAFN17112025004107003653ID1110352262

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.